Repeat of .23 cent run? The last run up to .23 cents

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Repeat of .23 cent run?

The last run up to .23 cents was, in my opinion, due mostly to a constant stream of PRs. It died down, among other things, because distribution wasn't able to keep up with demand and investors became bored.

SCIE has an incredible amount of energy building right now. Check it out:

This year alone, we've had SEVEN PR's in 5 months. NONE contained fluff. I know of countless stocks that haven't had seven PR's in three years.

The 10Q should be coming out tomorrow.

The last company to have a licensing agreement with Duke sold to Toshiba for over $10 a share. SCIE now has a licensing agreement with Duke.

Oncoscope acquisition isn't a long forgotten memory. Something big is in the works.

SCIE is probably working on a second device as we speak for Barrett's esophagus which uses Duke/Oncoscope tech. When we get a PR for this, its going to get cray-cray in here.

Medtech2017 in January. SCIE is on the FRONT webpage under JOHNSON & JOHNSON. Free publicity doesn't get any better than that!

SCIE is building distribution in China as we speak.

Wavstat4 is in the middle east. Possible sales from Saudi Arabia this year.

Europe sales very possible this year.

England is slowly coming on board. Probably hear about them in 2017 (could be sooner).

Tons of free publicity. Twitter accounts are picking up Spectrascience's PRs.

Barrett's esophagus website for cancer treatment shows SCIE's PR for Duke's agreement with SCIE.

The 10K showed $6600 in sales. $825 per box of forceps x 8 boxes = $6600. Coincidence? I don't think so. Someone bought them.

Dr. Neumann, ridiculously well known in the endoscopy world, has mentioned the success of the WavSTAT numerous times. Among other things, he also wrote about PENTAX's iSCAN found on the same PETAX website where the Wavstat is displayed.

JagWorldwide showed a picture last Friday of the wavstat in SPAIN. Hospitals aren't going to waste time, money, and resources training doctors and nurses if they aren't planning on buying it!

Standard biopsies are archaic! We are an internet connected, technologically advanced society. Optical biopsies are not only the 'future' of biopsies, they are coming online right now.

SCIE is working with PENTAX! Owned by HOYA!

Wavstat is on the PENTAX website.

Wavstat works with bladder lesions.

SCIE is at the forefront in this field. They own many patents which wont expire until 2020+. CEO Oliver probably wants to sell SCIE well before 2020. He's a successful business man and probably wants to retire with a bang.

Wavstat showing up on UK's NHS website numerous times.

MORDIS trial in effect; recruiting live human beings.

SCIE is extremely transparent with investors.

Chart showing an obvious turn around in trend. Higher lows since November 2015.

The wavstat is a real product, used on real humans, showing real results. I don't know about anyone else, but this list shows me the risk/reward ratio is worth my investment.

Not investment advice.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Updated Category News Views 0

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 0

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 0

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 0

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 0

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 0

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 0

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 0

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading

Top 5 Most Recently Viewed Articles

Gap Inc. Trading Halted Amid Earnings Report Confusion

Updated Category News Views 142

Gap Inc. Trading Halted Due to Earnings Report Mix-Up Trading for Gap shares was temporarily halted after the company mistakenly published its earnings report on its website, only to retract it shortly afterward. This unexpected event occurred just before the market closed, raising questions about the company's financial health. Preliminary Earnings Insights In spite of...

Continue Reading
XTrend Strengthens Commitment to Argentine National Team Sponsorship

Updated Category News Views 201

XTrend Strengthens Commitment to Sponsoring the Argentine National Team The Argentine Football Association (AFA) is excited to announce its renewed partnership with XTrend, which will continue as the official regional sponsor for the Argentine National Team. This collaboration marks a significant step forward in their ongoing relationship and aims to enhance XTrend's...

Continue Reading
Kurt Russell Sells AZZ Shares: What Investors Should Know

Updated Category News Views 141

Insider Selling Insights: Kurt Russell's AZZ Stock Sale Recently, Kurt L Russell, the Chief Strategy Officer at AZZ, made headlines with a notable sale of his company shares, marking a significant event in the financial landscape. The sale was reported around mid-August and is officially documented through an SEC filing. The Details of the Transaction According to the...

Continue Reading
Transforming the Future: SOFTSWISS and Crypto Trends 2025

Updated Category News Views 230

Transformative Trends in Cryptocurrency for 2025 Bitcoin has reached remarkable heights, breaking records and surpassing €100,000 per coin. This moment represents a significant chapter in the cryptocurrency saga. SOFTSWISS, a pioneering tech provider with extensive experience in crypto integration for iGaming, has identified key trends that are reshaping the digital...

Continue Reading
Drilling Tools International Corp. Delivers Solid Q3 2025 Gains

Updated Category News Views 177

Solid Performance for Drilling Tools International Corp. in Third Quarter 2025 Drilling Tools International Corp. (NASDAQ: DTI) continues to demonstrate resilience and strategic foresight in navigating the challenges of the oilfield services market. As the company reports its financial results for the third quarter of 2025, it is clear that careful planning and proactive...

Continue Reading